MOJIA BIOTECH (GUANG AN) LIMITED – Trademark Portfolio
Entity Type: 99
MOJIA BIOTECH (GUANG AN) LIMITED holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include MOJIA, MOJIABIO, and VIRIDIMIN.
No. 1, Shibin Road, Kuige Street,
Economic and Technological Development Zone, Guang?an City 638019 Sichuan Province
Showing of trademarks Trademarks
Trademark Classifications
MOJIA BIOTECH (GUANG AN) LIMITED's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does MOJIA BIOTECH (GUANG AN) LIMITED have?
MOJIA BIOTECH (GUANG AN) LIMITED has 4 U.S. trademarks filed with the USPTO. Of these, 4 registered.
What trademark classes does MOJIA BIOTECH (GUANG AN) LIMITED file in?
MOJIA BIOTECH (GUANG AN) LIMITED files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are MOJIA BIOTECH (GUANG AN) LIMITED's most well-known trademarks?
MOJIA BIOTECH (GUANG AN) LIMITED's registered trademark portfolio includes well-known marks such as MOJIA, MOJIABIO, and VIRIDIMIN. These are among 4 currently registered trademarks in the portfolio.
What is MOJIA BIOTECH (GUANG AN) LIMITED's trademark registration success rate?
MOJIA BIOTECH (GUANG AN) LIMITED has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.